key: cord-0996766-1j3ypm0u
authors: Brady, William J.; Chavez, Summer; Gottlieb, Michael; Liang, Stephen Y.; Carius, Brandon; Koyfman, Alex; Long, Brit
title: Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings
date: 2022-04-27
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2022.04.031
sha: 82c28ae84d33fcc041c654730fb71267c3051f96
doc_id: 996766
cord_uid: 1j3ypm0u

INTRODUCTION: Coronavirus disease of 2019 (COVID-19) has resulted in millions of cases worldwide. As the pandemic has progressed, the understanding of this disease has evolved. Its impact on the health and welfare of the human population is significant; its impact on the delivery of healthcare is also considerable. OBJECTIVE: This article is another paper in a series addressing COVID-19-related updates to emergency clinicians on the management of COVID-19 patients with cardiac arrest. DISCUSSION: COVID-19 has resulted in significant morbidity and mortality worldwide. From a global perspective, as of February 23, 2022, 435 million infections have been noted with 5.9 million deaths (1.4%). Current data suggest an increase in the occurrence of cardiac arrest, both in the outpatient and inpatient settings, with corresponding reductions in most survival metrics. The frequency of out-of-hospital lay provider initial care has decreased while non-shockable initial cardiac arrest rhythms have increased. While many interventions, including chest compressions, are aerosol-generating procedures, the risk of contagion to healthcare personnel is low, assuming appropriate personal protective equipment is used; vaccination with boosting provides further protection against contagion for the healthcare personnel involved in cardiac arrest resuscitation. The burden of the COVID-19 pandemic on the delivery of cardiac arrest care is considerable and, despite multiple efforts, has adversely impacted the chain of survival. CONCLUSION: This review provides a focused update of cardiac arrest in the setting of COVID-19 for emergency clinicians.

in late 2019 in Wuhan, China before spreading rapidly around the globe, reaching pandemic status on March 11, 2020 [9-12] . As of February 23, 2022, 429 million cases have been diagnosed worldwide with 5.9 million deaths [13] . In the COVID-19 pandemic era, cardiac arrest is occurring more often and is associated with an extremely high mortality rate (as much as 100% for COVID-19 patients experiencing IHCA) and poor resultant functional status (6.3% with good neurologic outcomes at 30 days; 95% confidence interval [CI] 0.4-9.7%) [14 -18] .

COVID-19 may result in cardiorespiratory compromise in those with severe disease and those with underlying cardiorespiratory conditions [19] . Fear of contagion and limited resource availability have impacted patient access to medical care [19] [20] [21] . Furthermore, the high demand for service has understandably delayed urgent treatment, which may result in cardiac arrest [20] . In fact, many centers have reported a reduction in the presentation of ST segment elevation myocardial infarction (STEMI) and cerebrovascular accident (CVA) during the pandemic, with many of these patients staying home with their illness and potentially risking cardiac arrest [21] .

For OHCA, the incidence of OHCA has increased while survival rates have declined commensurately with in several studies, which may be due to several important factors [11, [22] [23] [24] [25] [26] . Due to concerns of viral spread, bystanders may be less willing to intervene in OHCA [27] [28] [29] [30] . Because of social distancing and quarantines, the likelihood of a witnessed arrest occurring in public, with a knowledgeable bystander capable of performing CPR and/or applying an automated external defibrillator (AED) may have decreased [30] . Additionally, according to one meta-analysis, field terminations (odds ratio [OR] = 2.46, 95% CI 1.62-3.74) and J o u r n a l P r e -p r o o f asphyxial etiologies (OR = 1.17, 95% CI 1.02-1.33) have increased, while rates of shockable rhythm (OR = 0.73, 95% CI 0.60-0.88), ROSC (OR = 0.65, 95% CI 0. 55-0.77) , and survival to hospital admission (OR = 0.55, 95% CI 0. 48-0.89) have decreased compared to the pre-pandemic period [30] .

Similarly, the COVID-19 pandemic has adversely affected IHCA care and outcomes. Prior to the COVID-19 era, significant variation existed among hospitals regarding IHCA care and survival outcomes; the pandemic has only accentuated this variation [31] . IHCA is also more likely to be associated with a non-shockable rhythm (76.5%) and occur in the ICU (73.7%) [32] . Factors such as emphasis on healthcare personnel use of personal protective equipment (PPE) prior to contact, increased patient volume, and strained resources impact response times and subsequent outcomes [17,31].

A literature review of PubMed, Ovid Medline, and Google Scholar databases was performed for articles up to January 31, 2022, using the keywords 'COVID' OR 'COVID-19' OR 'SARS-CoV-2' OR 'coronavirus' AND 'cardiac arrest' OR 'heart arrest' for this narrative review. The authors included retrospective and prospective studies, systematic reviews and meta-analyses, clinical guidelines, and other narrative reviews. Commentaries and letters were also included. The literature search was restricted to studies published in English. Authors reviewed all relevant articles and decided which studies to include for the review by consensus, with a focus on emergency medicine-focused and -relevant articles, including guidelines. At least two authors reviewed each included article with an additional author added if disagreement note OHCA cases may be underestimated due to limitations in data collection [ 

Patients presenting with OHCA are, by definition, critically ill from the start; little information is typically available to the care team as they initiate resuscitation. When compared to pre-pandemic data, patients experiencing OHCA during the COVID-19 pandemic more often were in non-public locations and were unwitnessed [39, 41] . In the subgroup of patients who experienced cardiac arrest after calling for EMS assistance, J o u r n a l P r e -p r o o f the most frequent chief complaints were dyspnea, cough, fever, chest pain, altered level of consciousness, and "sick person" [39, 41] . Prior to the onset of EMS-witnessed cardiac arrest, these patients frequently demonstrated respiratory distress with sinus tachycardia, tachypnea, and low oxygen saturations. After EMS evaluation, oxygen saturations in the lower eighty percent range and less, while not predictive of cardiac arrest, were seen frequently in these patients. Non-shockable cardiac arrest rhythms, including asystole and pulseless electrical activity, were encountered much more often [39, 41] .

This increase in non-shockable rhythms [62] in the out-of-hospital setting could result from several issues, including delayed EMS response times, more frequent unwitnessed events, and less frequent application of pre-arrival care by bystanders; furthermore, a likely increase in non-cardiogenic cardiac arrest physiology (i.e., respiratory mediated with hypoxia, hypercarbia, and/or acidosis) likely also contributes to this higher rate of pulseless electrical activity and asystole.

Among patients with IHCA, more medical information is usually available regarding the peri-arrest period. The location of cardiac arrest is the ICU in most instances, although many studies report an increase in IHCA on non-critical care units; In fact, one study demonstrated that patients admitted to non-ICU level of care suffered J o u r n a l P r e -p r o o f rapid clinical deterioration, often with a sudden decrease in oxygen saturation, immediately prior to cardiac arrest [52] . Cardiac arrest later in the hospital course more frequently occurs in the ICU; these patients are often already receiving maximal supportive care with mechanical ventilation, vasopressor infusion, and hemodialysis. Either significant multilobar pneumonia or adult respiratory distress syndrome is frequently present; these patients tend to have more gradual, additional decompensation, leading to cardiac arrest. As would be expected among inpatients with multiorgan failure, significant hypoxic, hypercarbic respiratory failure, and nonshockable rhythms are common with pulseless electrical activity predominating 

As is widely known, a primary strategy in the management of the OHCA patient is known as the "chain of survival" concept, which emphasizes a system-of-care approach that includes early access to care and consists of five key links: (1) recognition of cardiac arrest and activation of the response system; (2) Considering the early impact of social isolation and mandatory building closures, a Canadian study compared AED accessibility measured by density of foot traffic for a range of locations with reported AEDs. They noted that 69.9% of public access AEDs were completely inaccessible, 18.8% were partially inaccessible, and 11.3% were unaffected (i.e., accessible). They. noted that recreational parks, retail and recreation locations, and workplaces experienced the greatest reduction in AED accessibility; they also reported that the greatest discrepancies between foot traffic levels and AED accessibility occurred in parks, retail and recreation locations, and transit The patient experiencing cardiac arrest with suspected COVID-19 should immediately be placed in an airborne infection isolation room (AIIR) if such a resource is avaialbe, also referred to as a negative pressure room; alternatively, if not possible, a private room with a closed door is strongly encouraged. During the resuscitation of cardiac arrest, healthcare personnel may be required to perform aerosol generating procedures (AGPs) such as bag-mask ventilation, airway suctioning, endotracheal intubation (ETI), and chest compressions (Table 1) . Performing AGPs in an AIIR reduces cross-contamination among staff and patients outside the room; importantly, resuscitation team personnel can still be exposed to and contaminated with viral particles in these rooms. While many healthcare facilities have developed novel alterations to existing patient care spaces with the ability to convert to negative pressure status, these rooms are still a limited resource. Furthermore, as seen in many instances of IHCA related to COVID-19, The number of IHCA team members allowed to enter the room and engage in care must be limited. It is also appropriate to limit the number of healthcare personnel in the resuscitation room, primarily to reduce the number of COVID-19-exposed J o u r n a l P r e -p r o o f individuals but also to rationally use (and thus conserve) PPE. The actual number of team members in the resuscitation room will vary based upon several factors, including local personnel resource availability, practice patterns, and patient needs. Immediately outside the resuscitation room or area, additional personnel can be stationed, including a pharmacist, nurse serving as a safety officer, and patient care technician for other duties as needed [70] [71] [72] .

Any equipment or personnel that do not require immediate entry into the patient room should remain in the hallway for prompt access. For example, the code cart with appropriate medications and supplies can remain in the hallway immediately adjacent to the doorway. The safety officer or other assigned personnel can provide rapid access to any requested medications, supplies, or equipment. With this approach, the code cart and its contents do not need to be discarded afterwards due to contamination. Conversely, the monitor-defibrillator and appropriate cables for monitoring and delivery of therapy likely will require placement in the room, adjacent to the patient; after care has been rendered, this device will need to be decontaminated

In the approach to cardiac arrest during the pandemic, it should be assumed that 

All airway and breathing interventions are considered AGPs to varying degrees and thus pose a contagion risk to the resuscitation team. Such interventions must be performed using appropriate PPE. Management of the airway and breathing status has different priorities depending upon the etiology of the cardiac arrest. Non-cardiogenic events, particularly those events involving compromised respiratory function, have a markedly higher airway management priority as compared to cardiogenic cardiac arrests. This statement has been clearly established prior to the pandemic and remains a standard approach since the advent of COVID-19. In general, earlier application of a definitive airway with oxygenation and ventilation is appropriate for certain noncardiogenic events.

Upon entering the room following appropriate donning of PPE, application of a preferably using a two-person technique, to ensure best-possible oxygenation and ventilation, as well as to limit contagion risk [72, 86] . The HEPA filter is placed in line along the exhalation port of most respiratory devices used in resuscitation, including the bag-mask ventilation, supra-glottic airway, endotracheal tube, and mechanical ventilation. The HEPA filter is a pleated mechanical air filter that can theoretically remove up to 99.97% of particulate matter in the air down to a size of 0.3 microns, including dust, pollen, and various microbes including viral particles. The HEPA filter is recommended by many authorities for such application [72] . Alternatives to the HEPA filter include the low-dead space viral filter or a heat and moisture exchanging filter (HMEF) with at least 99.99% viral filtration efficiency may be placed in the circuit, between ventilation device and the airway.

The next consideration in respiratory management is insertion of an advanced airway, including either a supra-glottic airway (SGA) or an endotracheal tube (ETT), using an in-line HEPA filter. Placement of an advanced airway as early as possible will reduce the risk of aerosolization while maximizing patient care, assuming that other interventions are not adversely impacted by any airway management-associated treatment delays and appropriate resources are available for such. Placement of an advanced airway should occur as soon as clinically feasible, once the resuscitation team is in position and appropriate personnel are available [72] . In fact, numerous authorities recommend that the initiation of airway management in the COVID-19 J o u r n a l P r e -p r o o f patient experiencing cardiac arrest should begin with placement of the advanced airway, omitting the earlier steps noted above [72] .

The decision regarding which type of advanced airway used must consider several factors, including individual patient needs, resource availability, and team member expertise. If an SGA is selected, it should be placed in conjunction with a HEPA filter. If endotracheal intubation is selected as the advanced airway strategy, video laryngoscopy, if available,as compared to direct laryngoscopyis preferred in that the former allows for an increased distance between the patient and the airway management team member [72, [90] [91] [92] . Furthermore, in an effort to reduce the AGP nature of the chest compressionairway management combination, the AHA recommends that chest compressions be paused during intubation to reduce risk of disease transmission and ensure first-pass intubation success [72] . This represents a significant change from pre-pandemic recommendations to insert an advanced airway with minimal to no interruption in chest compression; an approximate 10-second compression pause is considered appropriate in this setting. As with the SGA strategy, once the ETT is confirmed in correct placement, a HEPA filter should be attached to further limit the risk of viral aerosolization and reduce contagious risk.

If the patient has already been endotracheally intubated and is on mechanical ventilation at the time of cardiac arrest, consider leaving the patient on the ventilator with an in-line HEPA filter; such a strategy maintains the closed circuit and significantly reduces the chance of contagion. If this strategy is pursued, the resuscitation team must adjust the ventilator settings to allow asynchronous ventilations, allowing for the delivery of appropriate tidal volumes and using the following suggestions: maximize the J o u r n a l P r e -p r o o f Journal Pre-proof FiO2 to 100%; use either pressure or volume control ventilation with the limitations to either pressure or tidal volume to generate adequate chest rise (4-6 mL/kg ideal body weight); adjust the trigger settings to prevent the ventilator from auto triggering with chest compressions; maintain respiratory rate at 10 breaths/min for adults; adjust the positive end-expiratory pressure setting as needed, considering lung volume expansion and systemic blood pressure; to balance lung volumes and venous return; and maintain a closed circuit with HEPA filter to reduce the opportunity for aerosol generation and contagion [72] .

The risk of aerosol generation during CPR remains poorly understood [93, 94] . In a mannequin and cadaver study, compression-only CPR was shown to disperse 

Once ROSC is achieved and maintained, the patient likely requires additional resuscitation and supportive care. As is true in non-COVID-19 patients, the resuscitation team should assess / re-assess the patient using the airway, breathing, circulation, and disability approach [105] . Airway and breathing must be first addressed. If deficiencies in maintaining a stable airway and/or inadequate oxygenation or ventilation are found, then definitive management must occur as soon as clinically feasible; if the patient was not intubated during the period of active cardiac arrest, endotracheal intubation with mechanical ventilation should follow. Support of appropriate perfusion is the next priority with use of intravenous fluids, blood products, and vasopressor infusion (likely norepinephrine), as indicated by the clinical specifics of the resuscitated patient; in addition, malignant and/or compromising dysrhythmias should be managed in standard fashion. Attention to co-existing issues such as hypoglycemia, CVA, etc that could not only cause the event but also contribute to continued altered mentation should also be considered at this time. Targeted temperate management can also be considered using the pre-COVID-19 criteria; the avoidance of hyperthermia is strongly encouraged as well [105].

The COVID-19 pandemic has most certainly adversely impacted the health and safety of the human population. It has not only introduced a new illness with significant J o u r n a l P r e -p r o o f morbidity and mortality but also exacerbated many pre-existing medical conditions. Considering cardiac arrest, both out of and in the hospital setting, the COVID-19 pandemic has contributed to a significant increase in its occurrence as well as a simultaneous reduction in neurologically intact survival rates, negatively impacting both those individuals with and without viral infection. While many interventions, including chest compressions, are aerosol-generating procedures, the risk of contagion to healthcare personnel is low, assuming appropriate personal protective equipment is used; vaccination against the COVID-19 virus with appropriate boosting provides further protection against contagion for the healthcare personnel involved in cardiac arrest resuscitation. 

• Appropriate use of PPE is essential for healthcare personnel safety to reduce risk of infection. • All providers should wear an N-95 respirator (or equivalent) and other appropriate PPE (gown, gloves, eye protection) when performing AGP (i.e., CPR, airway intervention). • Persons not wearing PPE should leave the room/area immediately. • Healthcare personnel can significantly reduce their risk of infection, severe illness, and death through receiving vaccine and booster against SARS-CoV-2. 

Cardiac arrest: resuscitation and reperfusion

Survival rates in out-of-hospital cardiac arrest patients transported without prehospital return of spontaneous circulation: an observational cohort study

The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis

Out-of-hospital cardiac arrest survival improving over time: Results from the Resuscitation Outcomes Consortium (ROC)

Hospital variation in survival after inhospital cardiac arrest

The Evolving Role of the Cardiac Catheterization Laboratory in the Management of Patients With Out-of-Hospital Cardiac Arrest: A Scientific Statement From the

Causes of in-hospital cardiac arrest -incidences and rate of recognition

Clinical Characteristics of Coronavirus Disease 2019 in China

Cardiovascular disease and COVID-19

COVID-19 and the cardiovascular system

general-s-opening-remarks-at-the-media-briefing-on-covid

COVID-19 Map, Johns Hopkins Coronavirus Resource Center

Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19

Is Cardiopulmonary Resuscitation Futile in Coronavirus Disease 2019 Patients Experiencing In-Hospital Cardiac Arrest?

Outcomes for inhospital cardiac arrest for COVID-19 patients at a rural hospital in Southern California

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan

Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis

Cardiac Manifestations Of Coronavirus (COVID-19)

Cardiovascular Deaths During the COVID-19 Pandemic in the United States

Impact of COVID-19 Pandemic on Critical Care Transfers for ST-Segment-Elevation Myocardial Infarction, Stroke, and Aortic Emergencies

Lay Responder Care for an Adult with Out-of-Hospital Cardiac Arrest

Effects of the COVID-19 pandemic on outof-hospital cardiac arrest care in Detroit

Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy

The Effect on the Out-of-Hospital System of Patients With Out-of-Hospital Cardiac Arrest During the COVID-19 Outbreak in One City in China

Effects of COVID-19 on in-hospital cardiac arrest: incidence, causes, and outcome -a retrospective cohort study

Impact of COVID-19 on Out-of-Hospital Cardiac Arrest in Singapore

A quantitative assessment of the contribution of "citizen First Responder" in the adult out-of-hospital chain of survival during COVID-19 pandemic

First responder cardiac health amid the COVID-19 pandemic

Impact of the COVID-19 pandemic on the epidemiology of out-of-hospital cardiac arrest: a systematic review and metaanalysis. Ann Intensive Care

Association between Hospital volume of cardiopulmonary resuscitation for in-hospital cardiac arrest and survival to Hospital discharge

In-hospital cardiac arrest in patients with coronavirus 2019

The impact of COVID-19 on the epidemiology, outcome and management of cardiac arrest

Excess Cardiac Arrest in the Community During the COVID-19 Pandemic

COVID-19 kills at home: the close relationship between the epidemic and the increase of out-of-hospital cardiac arrests

Out-of-hospital cardiac arrest during the COVID-19 pandemic

Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences

Out-of-hospital cardiac arrest incidence during COVID-19 pandemic in Southern Germany

Incidence and outcome of out-of-hospital cardiac arrests in the COVID-19 era: A systematic review and meta-analysis

Out-of-Hospital Cardiac Arrest in London during the COVID-19 pandemic

Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic

Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease

Collateral damage: Hidden impact of the COVID-19 pandemic on the out-of-hospital cardiac arrest systemof-care

Cardiac arrest in COVID-19: characteristics and outcomes of in-and out-of-hospital cardiac arrest. A report from the Swedish Registry for Cardiopulmonary Resuscitation

Use of out-of-hospital cardiac arrest registries to assess COVID-19 home mortality

Variation in community and ambulance care processes for out-of-hospital cardiac arrest during the COVID-19 pandemic: a systematic review and meta-analysis. Sci Rep

Characteristics and Outcomes of In-Hospital Cardiac Arrest Events During the COVID-19 Pandemic: A Single-Center Experience From a New York City Public Hospital

Predictors, and Outcomes of In-Hospital Cardiac Arrest in COVID-19 Patients Admitted to Intensive and Non-Intensive Care Units: Insights From the AHA COVID-19 CVD Registry

The Influence of COVID-19 on Out-Hospital Cardiac Arrest Survival Outcomes: An Updated Systematic Review and Meta-Analysis

In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study

Outcomes of in-hospital cardiac arrest in patients with COVID-19 in

Clinical Mortality in a Large COVID-19 Cohort: Observational Study

Access to intensive care in 14 European countries: a spatial analysis of intensive care need and capacity in the light of COVID-19

The Variety of Cardiovascular Presentations of COVID-19

Cohort study of the characteristics and outcomes in patients with COVID-19 and in-hospital cardiac arrest

Mechanisms of thrombosis and cardiovascular complications in COVID-19

Trajectories of vital signs in patients with COVID-19

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19) [published correction appears in JAMA Cardiol

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

COVID-19 and Venous Thromboembolism in Intensive Care or Medical Ward

Forty Postmortem Examinations in COVID-19 Patients

Out-of-hospital cardiac arrest prognosis during the COVID-19 pandemic

American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

S685-S705

The chain of survival: Not all links are equal. Resuscitation

Surviving out-of-hospital cardiac arrest: The important role of bystander interventions

Impact of Bystander Automated External Defibrillator Use on Survival and Functional Outcomes in Shockable Observed Public Cardiac Arrests

In-hospital cardiac arrest: are we overlooking a key distinction

Impact of the COVID-19 pandemic on cardiac arrest systems of care

The need to adapt the rescue chain for out-of-hospital cardiac arrest during the COVID-19 pandemic: Experience from the Paris Fire Brigade Basic Life Support and Advanced Life Support teams

Public defibrillator accessibility and mobility trends during the COVID-19 pandemic in Canada

COVID-19 cardiac arrest management: A review for emergency clinicians

Interim Guidance for Emergency Medical Services Management of Out-of-Hospital Cardiac Arrest During the COVID-19

Interim Guidance to Healthcare Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates with Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With the Guidelines®-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration with the

Using simulation for training and to change protocol during the outbreak of severe acute respiratory syndrome

CDC Recommendations on Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings

Personal protective equipment for preventing highly infectious diseases due to exposure to contaminated body fluids in healthcare staff

Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19

Cardiopulmonary Resuscitation During the COVID-19 Pandemic: A View From Trainees on the Front Line

Impact of Personal Protective Equipment on the Performance of Emergency Pediatric Tasks

Chest Compression With Personal Protective Equipment During Cardiopulmonary Resuscitation: A Randomized Crossover Simulation Study

Influence of personal protective equipment on the performance of life-saving interventions by emergency medical service personnel

Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial

Prone cardiopulmonary resuscitation: A scoping and expanded grey literature review for the COVID-19 pandemic

Cardiopulmonary resuscitation in prone position: A scoping review

Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review

Risk factors for SARS transmission from patients requiring intubation: a multicentre investigation in Toronto

COVID-19 infection risk to rescuers from patients in cardiac arrest: Systematic Review

IO versus IV access while wearing personal protective equipment in a HazMat scenario

Impact of chemical, biological, radiation, and nuclear personal protective equipment on the performance of low-and high-dexterity airway and vascular access skills

Comparison of intravenous and intraosseous access by pre-hospital medical emergency personnel with and without CBRN protective equipment

Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists

Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease

Recommendations on cardiopulmonary resuscitation strategy and procedure for novel coronavirus pneumonia

COVID-19 in cardiac arrest and infection risk to rescuers: A systematic review

Should chest compressions be considered an aerosolgenerating procedure? A literature review in response to recent guidelines on personal protective equipment for patients with suspected COVID-19

Exploration of strategies to reduce aerosolspread during chest compressions: A simulation and cadaver model

Cardiopulmonary Resuscitation during the COVID-19 pandemic. Do supraglottic airways protect against aerosol-generation?

Aerosol generation during chest compression and defibrillation in a swine cardiac arrest model

Risk of SARS-CoV-2 Infection among Healthcare Providers Involved in Cardiopulmonary Resuscitation in COVID-19 Patients

Clinical Questions about COVID-19: Questions and Answers

Annex to Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel

COVID-19 disease: Resuscitation